In vivo evaluation of antioxydant potential and antihyperglycemic effect of Stevia rebaudiana Bertoni
Laen...
Kuupäev
2024
Kättesaadav alates
Autorid
Aissaoui, O.
Terki, L.
Ait Ameur, S.
Bitam, A.
Ajakirja pealkiri
Ajakirja ISSN
Köite pealkiri
Kirjastaja
Estonian University of Life Sciences
Abstrakt
Stevia rebaudiana Bertoni (SR) has a high concentration of phytochemicals that promote health and well-being in conditions such as diabetes. This study aims to assess the antihyperglycemic, antioxidant, and antihyperlipidemic effects of SR on diabetes in male rats caused by Alloxan. Forty adult male rats were divided into five groups. For 28 days, SR was administered by gavage. Spinreact and ELISA kits were used to detect serum levels of blood glucose, insulin, liver function, lipid profiles, antioxidant enzymes, and lipid peroxidation. Histopathology was also investigated. Stevia’s free radical scavenging capabilities have an IC50 value of between 34.49 and 39.66 mg L-1. Stevia therapy reduced biochemical markers in diabetic rats (DR). After 28 days, SR raised fasting blood glucose, insulin, and lipid peroxidation serum levels by 52%, 40%, and 27%, respectively. Also, in DR treated with SR, there was a substantial increase in high-density lipoprotein cholesterol (35.8%), superoxide dismutase (30%), total antioxidant status (20%), glutathione peroxidase and reductase. SR improves DR’s pancreas and liver function by enhancing the endogenous antioxidant system. These findings revealed that SR counteracted Alloxan’s necrotic effects by reducing insulin resistance in DR, hence revitalizing pancreatic β–cells.
Kirjeldus
Received: October 1st, 2023 ; Accepted: December 23rd, 2023 ; Published: January 22nd, 2024 ; Correspondence: aissaoui_ourida@univ-blida.dz
Märksõnad
HOMA-IR, glycemia, liver, oxidative stress, pancreas, Stevia, articles